Genovis Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Torben Jörgensen, was filed 12 May 2020.
Genovis: what insiders have been doing
Genovis is a listed company. Its directors and officers file their transactions with Finansinspektionen. The past year has been quiet: not a single insider filing for Genovis. The previous disclosure was published on 8 July 2020.
Since 2020, the database holds 3 purchases and no sales by insiders of the company.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Since the insiders bought
- +96.7%Entry 24.40 · Close at T+365 48.00
- +124.5%Entry 16.75 · Close at T+365 37.60
- +128.0%Entry 17.15 · Close at T+365 39.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 20,000 shares@ SEK 34.8543.1% of flowAktieISIN SE0002485979FI:csv-5be7a3b4ddb53d50d790
- 40,000 shares@ SEK 23.5056.9% of flowAktieISIN SE0002485979FI:csv-0a85a17440c563fb17c1Canonical exit: 9 Aug 2020 (T+90)
- 3,000 shares@ SEK 17.09100.0% of flowAktieISIN SE0002485979FI:csv-92bd28ed01a20182cfeaCanonical exit: 18 Jun 2020 (T+90)
- 5,160 shares@ SEK 19.35100.0% of flowAktieFI:csv-381e3471ba86304be7a1Canonical exit: 11 Jun 2020 (T+90)
4 of 4 declarations
About Genovis
Genovis is a company specializing in the development of technologies for biopharmaceuticals, particularly tools for antibody modification. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations